Patent Assignment
Reel/Frame 024927/0781
Change of Name
Recorded: 2010-09-02
Pages: 2
Assignor
ARANA THERAPEUTICS PTY LTD
Executed: 2010-02-10
Assignee
CEPHALON AUSTRALIA PTY LTD
RON KAL, LOCKED BAG 2053, NORTH RYDE NSW, 1670, AUSTRALIA
Covered Property
(1)
Binding Member Which Binds to Both Lewis-Y and Lewis-B Haptens, and Its Use for Treating Cancer
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 14, 2004
From: DURRANT, LINDA G.; PARSONS, TINA
To: SCANCELL LIMITED
Reel/Frame 015338/0901 →
Assignment of Assignor's Interest
Apr 4, 2008
From: SCANCELL LIMITED
To: ARANA THERAPEUTICS LIMITED
Reel/Frame 020753/0321 →
Change of Name
Sep 1, 2010
From: ARANA THERAPEUTICS LIMITED
To: ARANA THERAPEUTICS PTY LTD
Reel/Frame 024915/0819 →
Change of Name
Oct 24, 2013
From: CEPHALON AUSTRALIA PTY LTD
To: TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
Reel/Frame 031485/0784 →
Corrective Assignment to Correct the Correction of the Assignee Address to Remove "Ron Kal" from the Address Previously Recorded on Reel 031485 Frame 0784. Assignor(S) Hereby Confirms the Name Change from Cephalon Australia Pty Ltd to Teva Pharmaceuticals Australia Pty.
Feb 24, 2014
From: CEPHALON AUSTRALIA PTY LTD
To: TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
Reel/Frame 032403/0896 →